Renal changes on hyperglycemia and angiotensin-converting enzyme in type 1 diabetes

Hypertension

Volumn 33, Issue 3, 1999, Pages 775-780

  Marre, Michel ^a,b   Bouhanick, Béatrice ^a   Berrut, Gilles ^a   Gallois, Yves ^a   Le Jeune, Jean Jacques ^a   Chatellier, Gilles ^c   Menard, Joël ^d   Alhenc Gelas, François ^b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b Institute Nationale de Cancer   (France)

^c HÔPITAL BROUSSAIS   (France)

^d Centre Hospitalier Universitaire ^*

Author keywords

Angiotensin converting enzyme; Diabetic nephropathy; Genetics; Glomerular disease

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CLINICAL ARTICLE; DIABETIC NEPHROPATHY; DNA POLYMORPHISM; FEMALE; GENETIC RISK; GENOTYPE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY PLASMA FLOW; MALE; PRIORITY JOURNAL;

EID: 0033058415     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.33.3.775     Document Type: Article

References (41)

1. Norgaard K, Feldt-Rasmussen B, Borch-Johnsen K, Saelan H, Deckert T. Prevalence of hypertension in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1990;33:407-410.
2. Krolewski AJ, Warram JH, Rand LI, Kahn CR. Epidemiologic approach to the etiology of type I diabetes mellitus and its complications N Engl Med. 1987;317:1390-1398.
3. Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C, Dusselier L, Kahal Z, Chaillous L, Halimi S, Muller A, Sackmann H, Bauduceau B, Bled F, Passa P, Alhenc-Gelas F. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. J Clin Invest. 1997; 99:1585-1595.
4. Viberti GC, Keen H, Wiseman MJ. Raised arterial pressure in parents of proteinuric insulin-dependent diabetics. BMJ. 1987;295:515-517.
5. Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med. 1989;320:1161-1165.
6. Hall JE, Guyton AC, Jackson TE, Coleman TG, Lohmeier TE, Tripoddo NC. Control of glomerular filtration rate by renin-angiotensin system. Am J Physiol. 1977;233:F366-F372.
7. Hostetter TH, Troy JL, Brenner BM. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int. 1981;19:410-415.
8. Vane GR. Sites of conversion of angiotensin I. In: Genest J, Koine E, eds. Hypertension. Berlin, FRG: Springer-Verlag; 1972:523-532.
9. Alhenc-Gelas F, Baussant T, Hubert C, Soubrier F, Corvol P. The angiotensin I converting enzyme in the kidney. J Hypertens. 1989;7:S9-S13.
10. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion deletion polymorphism in angiotensin I converting enzyme gene accounting for half of the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
11. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest. 1986;77:1925-1930.
12. Marre M, Chatellier G, LeBlanc H, Guyenne TT, Menard J, Passa P. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ. 1988;297:1092-1095.
13. Lewis EJ, Hunsiker LG, Bain RP, Rohde RD, for the Collaborative Study Group. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993;329:1456-1462.
14. Mogensen CE. Glomerular filtration rate and renal plasma flow in normal and diabetic man during elevation of blood sugar levels. Scand J Clin Lab Invest. 1971;28:177-182.
15. Mauer SM, Steffes MW, Ellis EN, Sutherland DER, Brown DM, Goetz FC. Structural-functional relationship in diabetic nephropathy. J Clin Invest. 1984;74:1143-1155.
16. White NH, Skor D, Santiago JV. Practical closed-loop insulin delivery: a system for the maintenance of overnight euglycemia and the calculation of basal insulin requirements in insulin-dependent diabetics. Ann Intern Med. 1982;97:210-213.
17. Defronzo RA. The effect of insulin on renal sodium metabolism: a review with clinical implications. Diabetologia. 1981;21:165-171.
18. Marre M, LeBlanc H, Suarez L, Guyenne TT, Menard J, Passa P. Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. BMJ. 1987;294:1448-1452.
19. Danilov S, Savoie F, Lenoir B, Jeunemaitre X, Azizi M, Tarnow L, Alhenc-Gelas F. Development of enzyme-linked immunoassays for human angiotensin I converting enzyme suitable for large-scale studies. J Hypertens. 1996;14:719-727.
20. Goldstein DE, Little RR, England JD, Wiedmeyer HM, McKenzie EM. Methods for quantitating glycosylated hemoglobins: high-performance liquid chromatography and thiobarbituric acid colorimetry. In: Clarke WL, Larner J, Pohl SL, eds. Methods in Diabetes Research, Volume 2: Clinical Methods. New York, NY: John Wiley & Sons; 1986:475-504.
21. Menard J, Guyenne TT, Corvol P, Pau B, Simon D, Roncucci R. Direct immunometric assay of active renin in human plasma. J Hypertens. 1985;3(suppl 3):275-278.
22. Pham-Huu-Trung MT, Corvol P. A direct determination of plasma aldosterone. Steroids. 1974;24:587-598.
23. Heding LG, Larsen UD, Markussen J, Jorgensen KH, Hallund O. Radio-immunoassays for human, pork and ox C-peptides and related substances. In: Levine R, Pfeiffer EF, eds. Radioimmunoassay: Methodology and Applications in Physiology and in Clinical Studies. Stuttgart, FRG: Georg Thieme Publishers; 1974:40-44.
24. Visscher CA, De Zeeuw D, De Jong PE, Sluiter WJ, Huisman RM. Drug-induced changes in renal hippurate clearance as a measure of renal blood flow. Kidney Int. 1995;48:1617-1623.
25. Smith HW. Renal hemodynamics. In: The Kidney: Structure and Function in Health and Disease. Oxford, UK: Oxford University Press; 1951:575-601.
26. Armitage P, Berry G. Sequential methods. In: Statistical Methods in Medical Research. Oxford, UK: Blackwell Scientific Publications; 1990: 440-454.
27. Hostetter TH, Rennke HG, Brenner BM. The case for intra-renal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med. 1982;72:375-380.
28. Fujisawa T, Ikegami H, Kawaguchi Y, Hamada Y, Ueda H, Shintani M, Fukuda M, Ogihara T. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia. 1998;41:47-53.
29. Sirota JH, Baldwin DS, Villareal H. Diurnal variations of renal function in man. J Clin Invest. 1950;29:187-192.
30. Komers R, Allen TJ, Cooper ME. Role of endothelium derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes. Diabetes. 1994;43:1190-1197.
31. Tooke JE. Microvascular function in human diabetes: a physiological perspective. Diabetes. 1995;44:721-726.
32. Parving HH, Christiansen JS, Noer I, Tronier B, Mogensen CE. The effect of glucagon infusion on kidney function in short-term insulin-dependent juvenile diabetics. Diabetologia. 1980;19:350-354.
33. Christiansen JS, Gammelsgaard J, Frandsen M, Orskov H, Parving HH. Kidney function and size in type 1 (insulin-dependent) diabetic patients before and during growth hormone administration for one week. Diabetologia. 1982;22:333-337.
34. Ortola FV, Ballermann BJ, Anderson S, Mendez RE, Brenner BM. Elevated plasma atrial natriuretic peptide in diabetic rats: a potential mediator for hyperfiltration. J Clin Invest. 1987;80:670-674.
35. Blantz RC, Peterson OW, Gushwa L, Tucker BJ. Effect of modest hyperglycemia on tubuloglomerular activity. Kidney Int. 1982;22: S206-S212.
36. Graier WF, Wascher TC, Lackner L, Toplak H, Krejs GJ, Kukovetz WR. Exposure to elevated D-glucose concentrations modulate vascular endothelial cell vasodilatatory response. Diabetes. 1993;42: 1497-1505.
37. Ito S, Arima S, Ren YL, Juncos LA, Carretero OA. Endothelium derived factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole. J Clin Invest. 1993;91:2012-2019.
38. Fukumoto S, Ishimura E, Hosoi M, Kawagishi T, Kawamura T, Isshiki G, Nishizawa Y, Morii H. Angiotensin converting enzyme gene polymorphism and renal artery resistance in patients with insulin dependent diabetes mellitus. Life Sci. 1996;59:629-637.
39. Miller JA, Scholey JW, Thai K, Pei YPC. Angiotensin converting enzyme gene polymorphism and renal hemodynamic function in early diabetes. Kidney Int. 1997;51:119-124.
40. Mau-Pedersen M, Schmitz A, Pedersen EB, Danielsen H, Christiansen JS. Acute and long-term renal effects of angiotensin converting enzyme inhibition in normotensive, normoalbuminuric insulin-dependent diabetic patients. Diabet Med. 1988;5:562-569.
41. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med. 1984;311:89-93.